Phenserine on the Alzheimer's Treatment Horizon, Study 1

Clinical trial NCT06774261 · COMPLETED

Trial details

NCT number: NCT06774261
Sponsor: Helse Stavanger HF
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Mild Cognitive Impairment

Start date: 2025-02-01
Primary completion: 2025-12-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.